- Q1 2024 Zealand Pharma A/S Earnings Call TranscriptMay 16, 2024$91.15 (-4.36%)Earnings
- Full Year 2023 Zealand Pharma A/S Earnings Call TranscriptFeb 27, 2024$90 (-12.62%)Earnings
- Zealand Pharma A/S at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Zealand Pharma A/S Obesity R&D Event TranscriptDec 05, 2023
- Q3 2023 Zealand Pharma A/S Earnings Call TranscriptNov 09, 2023$41.91Earnings
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Zealand Pharma A/S Earnings Call TranscriptAug 17, 2023$35.19 (-0.45%)Earnings
- Zealand Pharma A/S at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Zealand Pharma A/S at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Zealand Pharma A/S Earnings Call TranscriptMay 11, 2023$35 (+7.36%)Earnings
- Zealand Pharma A/S at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Zealand Pharma A/S Annual Shareholders Meeting TranscriptMar 29, 2023
- Q4 2022 Zealand Pharma A/S Earnings Call TranscriptMar 02, 2023$32Earnings
- Zealand Pharma A/S at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Zealand Pharma A/S Earnings Call TranscriptNov 10, 2022$26.48Earnings
- Zealand Pharma A/S Corporate Call TranscriptSep 30, 2022
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Zealand Pharma A/S Earnings Call TranscriptAug 11, 2022$18.3 (+0.94%)Earnings
- Q1 2022 Zealand Pharma A/S Earnings Call TranscriptMay 12, 2022$11.14Earnings
- Zealand Pharma A/S at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Zealand Pharma A/S Corporate Update Call TranscriptMar 30, 2022
- Q4 2021 Zealand Pharma A/S Earnings Call TranscriptMar 10, 2022$14.35Earnings
- Q3 2021 Zealand Pharma A/S Earnings Call TranscriptNov 11, 2021$27.5 (-13.11%)Earnings
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Zealand Pharma A/S Earnings Call TranscriptAug 12, 2021$28.92Earnings
- Zealand Pharma A/S at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Q1 2021 Zealand Pharma A/S Earnings Call TranscriptMay 12, 2021$32.6Earnings
- Zealand Pharma A/S Corporate Call TranscriptMar 23, 2021
- Full Year 2020 Zealand Pharma A/S Earnings Call TranscriptMar 11, 2021$31.88Earnings
- Zealand Pharma A/S - Special Call TranscriptMar 05, 2021
- Zealand Pharma A/S - Pre Recorded Special Call TranscriptMar 04, 2021
- Q3 2020 Zealand Pharma A/S Earnings Call TranscriptNov 12, 2020$33.4Earnings
- Zealand Pharma A/S Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 10:30 AM TranscriptSep 14, 2020
- Q2 2020 Zealand Pharma A/S Earnings Call TranscriptAug 13, 2020$35.63Earnings
- Q1 2020 Zealand Pharma A/S Earnings Call TranscriptMay 14, 2020$24.6Earnings
- Zealand Pharma A/S at Needham Healthcare Conference TranscriptApr 15, 2020
- Zealand Pharma A/S Annual Shareholders Meeting TranscriptApr 02, 2020
- Full Year 2019 Zealand Pharma A/S Earnings Call TranscriptMar 12, 2020$25.7 (-28.31%)Earnings
- Valeritas Holdings, Inc., Zealand Pharma A/S - M&A Call TranscriptFeb 10, 2020
- Q3 2019 Zealand Pharma A/S Earnings Call TranscriptNov 14, 2019$33.1 (+3.70%)Earnings
- Zealand Pharma A/S Expands Its Peptide Platform with Acquisition of Encycle Therapeutics Inc Call TranscriptOct 22, 2019
- Half Year 2019 Zealand Pharma A/S Earnings Call TranscriptAug 15, 2019$21.86Earnings
- Q1 2019 Zealand Pharma A/S Earnings Call TranscriptMay 16, 2019$20.42Earnings
- Zealand Pharma A/S - Special Call TranscriptMar 21, 2019
- Q4 2018 Zealand Pharma A/S Earnings Call TranscriptMar 07, 2019$13.77Earnings
Zealand Pharma A/S Annual Shareholders Meeting Transcript
On behalf of the Board of Directors and Executive Board, I am pleased to welcome you to the Annual General Meeting 2023 of Zealand Pharma A/S. Today, the Board of Directors is represented by myself as Chairman and the Executive Board is represented by CEO, Adam Steensberg; and CFO, Henriette Wennicke. I would like to thank our shareholders for your attendance and continued support of the company. A year ago, we announced a change in strategy. We choose to prioritize investments in research and development. Zealand's core strength, as many of you already know, is the design and development of therapeutic peptides, and this has led to a rich pipeline of promising candidates targeting rare diseases, obesity and inflammation.
The company has demonstrated its ability to independently bring a product from discovery to market through the launch of Zegalogue in the U.S. However, Zealand also knows that to reach more patients in more regions around the world, the company should partner with global and regional leaders. Therefore, we scaled back Zealand's commercial operations and are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)